Bliss GVS Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has informed the stock exchanges that its trading window will be closed starting Wednesday, October 1, 2025. The window will remain shut until 48 hours after the company announces its unaudited financial results for the quarter and half year ended September 30, 2025 (Q2 FY26 and H1 FY26). During this period, insiders, designated persons, and their immediate relatives cannot buy, sell, or pledge shares of the company. The exact date of the board meeting to approve these results has not yet been disclosed and will be communicated separately.
This is a routine compliance filing under SEBI insider trading rules and does not directly impact shareholders. However, it signals that the company's Q2 and H1 FY26 earnings announcement is expected soon, which investors should watch for.